GABAPENTIN ENACARBIL EXTENDED RELEASE ORAL TABLET [HORIZANT]

Side Effects & Adverse Event Reports


View Chart Data

87.2K

Adverse Events

407.4K

Side Effects

2003

Data Starting In

SymPedia Mobile App

Get our Mobile App for easy access to the latest reports on GABAPENTIN ENACARBIL EXTENDED RELEASE ORAL TABLET [HORIZANT].

Understanding the potential Side Effects and Adverse Events of GABAPENTIN ENACARBIL EXTENDED RELEASE ORAL TABLET [HORIZANT] is essential for making informed health decisions. Our application provides in-depth reports based on real-world data, helping you explore how GABAPENTIN ENACARBIL EXTENDED RELEASE ORAL TABLET [HORIZANT] may affect your health.

View reports containing much more information including:

  • Age group - See how different age ranges experience side effects and adverse reactions.
  • Year - Track trends over time to understand changes in reported issues.
  • Biological sex - Compare how reports vary between men and women.
  • Weight - Examine the impact of body weight on side effects and adverse events.
Download Now

Frequently Asked Questions

Some questions about GABAPENTIN ENACARBIL EXTENDED RELEASE ORAL TABLET [HORIZANT] are asked frequently. We've answered the most frequent of those questions below

  • How many adverse events have been reported for GABAPENTIN ENACARBIL EXTENDED RELEASE ORAL TABLET [HORIZANT]?

    SymPedia shows GABAPENTIN ENACARBIL EXTENDED RELEASE ORAL TABLET [HORIZANT] adverse event reports for 87,246.

  • How many side effects have been reported for GABAPENTIN ENACARBIL EXTENDED RELEASE ORAL TABLET [HORIZANT]?

    SymPedia shows GABAPENTIN ENACARBIL EXTENDED RELEASE ORAL TABLET [HORIZANT] side effect reports for 407,413.

  • What year does the GABAPENTIN ENACARBIL EXTENDED RELEASE ORAL TABLET [HORIZANT] reporting data start?

    SymPedia reporting data on this page starts in 2003.

  • What years are included in the yearly chart for GABAPENTIN ENACARBIL EXTENDED RELEASE ORAL TABLET [HORIZANT]?

    SymPedia yearly chart data on this page covers 2003 to 2025.